Acute intermittent porphyria: Prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France

Journal of Internal Medicine

Volumn 242, Issue 3, 1997, Pages 213-217

  Nordmann, Y ^a   Puy, H ^a   Da Silva, V ^a   Simonin, S ^a   Robreau, A M ^a   Bonaiti, C ^b   Phung, L N ^a   Deybach, J C ^a  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Acute intermittent porphyria; Gene mutations

Indexed keywords

AMINOLEVULINIC ACID; PORPHOBILINOGEN; PORPHOBILINOGEN DEAMINASE;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; ENZYME ACTIVITY; FRANCE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MUTATION RATE; NORMAL HUMAN; PEDIGREE; PRIORITY JOURNAL;

EID: 0030799468     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00189.x     Document Type: Article

References (14)

1. Elder GH. Metabolic abnormalities in the porphyrias. Sem Dermatol 1986; 5: 88-98.
2. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 7th edn. New York, USA: McGraw-Hill, 1995; 2103-59.
3. Saint EG, Curnow DH. Porphyria in Western Australia. Lancet 1962; 1: 133-6.
4. Waldenström J. The porphyrias as inborn errors of metabolism. Am J Med 1957; 22: 758-73.
5. Meyer UA, Strand L, Doss M, Rees AC, Marver HS. Intermittent acute porphyria. Demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med 1972; 286: 1277-82.
6. Mustajoki P, Kauppinen R, Lannfelt L, Lilius L, Koistinen J, Frequency of low erythrocyte porphobilinogen deaminase activity in Finland. J Int Med 1992; 231: 389-95.
7. Sassa S, Granick S, Bickers DS, Bradlow HL, Kappas A. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease. Proc Nat Acad Sci (USA) 1974; 71: 732-6.
8. Chretien S, Dubart A, Beaupain D, Raich N, Grandchamp B, Rosa J et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Nat Acad Sci (USA) 1988; 85: 6-10.
9. Deybach JC, Puy H. Porphobilinogen deaminase gene structure and molecular defects. J Bioenerg Biomembranes 1995; 27: 197-205.
10. Myers RM, Maniatis T, Lerman LS. Detection and localisation of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 1987; 155: 501-27.
11. Bonaïti-Pellie C, Phung L, Nordmann Y. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a bayesian approach. Am J Med Genet 1984; 19: 755-62.
12. Mgone C, Lanyon W, Moore M, Louie G, Connor J. Detection of high mutation frequency in exon 12 of the porphobilinogen deaminase gene in patients with acute intermittent porphyria. Hum Genet 1993; 92: 619-22.
13. Gu XF, de Rooij F, Voortman G, Te Velde K, Deybach JC, Nordmann Y, Grandchamp B. Detection of eleven mutations causing acute intermittent porphyria using denaturing gradient gel electrophoresis. Hum Genet 1994; 93: 47-52.
14. Tishler PV, Woodward B, O'Connor J, Holbrook DA, Seidman LJ, Hallett M, Knighton DJ. High prevalence of acute intermittent porphyria in a psychiatric patient population. Am J Psychiatry 1985; 142: 1430-36.